Sugar Coating and Cellular Switches

How Barbara Imperiali Illuminates Life's Molecular Machinery

Article Navigation

The Bridge Builder

Molecular structure

At the bustling intersection of chemistry and biology, Barbara Imperiali stands as a master architect. As the Class of 1922 Professor of Biology and Chemistry at MIT, Imperiali has spent her career designing molecular tools that illuminate biological processes invisible to conventional approaches.

Her work—spanning protein glycosylation in bacteria and kinase signaling in human cells—addresses fundamental questions with profound implications. How do sugars control protein function? How do cellular switches drive diseases like cancer? For Imperiali, the answers lie in chemical innovation.

Key Honors
  • Elected to the National Academy of Sciences
  • Fellow of the Royal Society
  • Class of 1922 Professor at MIT

The Making of a Molecular Architect

From London to MIT: Foundations of a Hybrid Scientist

Imperiali's scientific journey began at the University College London, where a degree in Medicinal Chemistry (1979) ignited her passion for molecular design. Her PhD at MIT under Satoru Masamune (1983) focused on synthesizing ansamycin antibiotics—a project demanding intricate organic chemistry 3 6 .

"I've always thought like a chemist. The molecules are in my head, but biology reveals the problems to solve" 4 .

Caltech: The Crucible of Chemical Biology

In 1989, Imperiali joined Caltech, where colleague Dennis Dougherty inspired her to apply "unnatural amino acid mutagenesis" to probe proteins. At the time, few chemists dared tackle membrane-associated biological problems.

"We weren't afraid to leap over the Chem/Bio border" 4 .

Her boldness led to a career-defining move: co-founding the first Gordon Research Conference in Bioorganic Chemistry (1992). This forum united pioneers in what we now call chemical biology, cementing it as a distinct field 4 5 .

Decoding Sugar's Secret Language

Glycosylation: Life's Sugar Code

Over 50% of human proteins are decorated with sugars—a process called glycosylation. These sugar coats ("glycans") dictate protein folding, stability, and cellular communication. Imperiali's lab focuses on N-linked glycosylation, where sugars attach to asparagine residues. In bacteria, this process isn't just vital—it's a virulence factor. Pathogens like Campylobacter jejuni use glycans to invade host cells 1 8 .

The Membrane Puzzle

N-linked glycosylation begins with phosphoglycosyl transferases (PGTs), enzymes embedded in cell membranes. PGTs catalyze the first membrane-bound step: attaching a sugar-phosphate to a lipid carrier.

For decades, studying PGTs stalled due to:

  1. Extraction challenges: Their membrane location complicates purification.
  2. Primitive assays: Reliance on radioactive labels or multi-enzyme systems .

UMP-Glo Assay Revolution

A Flash of Insight

In 2016, Imperiali's team cracked the PGT assay problem with a luminescence-based method called UMP-Glo . The breakthrough leveraged a simple fact: all PGT reactions release uridine monophosphate (UMP) as a byproduct. By quantifying UMP, they could measure PGT activity directly.

Results That Resonated

The team validated UMP-Glo across diverse PGTs:

  • PglC (Helicobacter pullorum): Km = 18.2 µM for UDP-GlcNAc
  • WecA (Thermatoga maritima): Activity retained after detergent extraction

Compared to radioactive assays, UMP-Glo offered:

  • 100x higher sensitivity (detecting pmol UMP)
  • 90% less time (results in 1 hour vs. overnight)
  • Full compatibility with high-throughput screens .
How UMP-Glo Works
  1. Reaction Setup: Purified PGT is mixed with its substrates: a uridine diphosphate-sugar and a polyprenyl phosphate lipid carrier.
  2. Enzymatic Transfer: PGT catalyzes sugar transfer to the lipid, releasing UMP.
  3. Detection Cascade:
    • UMP is converted to UTP
    • UTP fuels luciferase-generated light
    • Luminescence intensity correlates with UMP concentration
Table 1: UMP-Glo vs. Traditional PGT Assays
Method Sensitivity Time Required Throughput
Radioactive Moderate >12 hours Low
HPLC-Based High 2-4 hours Moderate
UMP-Glo Very High 1 hour High

Lighting Up Cellular Signals: Kinase Probes

The Kinase Problem

Kinases—enzymes that add phosphate groups to proteins—orchestrate cell growth, metabolism, and death. When misfiring, they drive cancer and neurodegenerative diseases. Yet drug developers struggled to track kinase-inhibitor interactions in real time.

"You need traffic lights for kinase pathways. Misfiring kinases leave the green light on forever, causing cells to proliferate wildly" 8 .

From Lab to Startup

In 2015, Imperiali co-founded AssayQuant Technologies to commercialize these probes. The kits now cover 120+ kinases, enabling:

  • Drug screening: Identifying kinase inhibitors in microplate format.
  • Diagnostic potential: Profiling kinase activities in tumors 8 .
Peptide Probes with a Fluorescent Twist

Imperiali's solution: synthetic peptides mimicking kinase substrates, embedded with environment-sensitive fluorophores. When a phosphate group attaches, fluorescence intensity or wavelength shifts—acting like a molecular "on-off" light 1 8 .

Table 3: Applications of Imperiali's Kinase Probes
Application Probe Design Impact
High-throughput screening Phospho-sensitive fluorescent peptides Identifies drug candidates in hours
Cellular imaging FRET-based kinase reporters Visualizes kinase activity in live cells
Cancer diagnostics Multi-kinase sensor arrays Profiles tumor signaling pathways

Educator, Mentor, and Trailblazer

Teaching the Next Generation

Imperiali's passion extends beyond the lab. At MIT, she teaches introductory biology and chemical biology, earning the Margaret MacVicar Fellowship (2003–2013) for redefining undergraduate education. Her textbook, Chemical Glycobiology, trains scientists to tackle glycosylation's complexities 5 9 .

Building a Legacy

Her mentorship birthed leaders like Sarah O'Connor (Director, Max Planck Institute) and Eranthie Weerapana (Professor, Boston College). Lab members praise her hands-on guidance:

"Barbara taught us to fearlessly blend tools—whether bioinformatics, synthesis, or single-molecule imaging" 3 9 .

The Road Ahead: Diagnostics and Disruption

Glycan-Based Diagnostics

Imperiali's newest venture targets bacterial diagnostics using sugars. Pathogens display unique glycans; detecting them could revolutionize infection diagnosis. Early work uses synthetic lectins (sugar-binding proteins) to profile bacterial surfaces 2 8 .

A Vision Realized

From PGT inhibitors to kinase sensors, Imperiali's tools share a mission: democratizing access.

"Good tools belong in every lab—not just those with radioactive permits or million-dollar robots" 4 .

When not in the lab, she backpacking "off the grid"—a fitting metaphor for a scientist who reshapes scientific frontiers 9 .

"You can't go uphill. You can roll down from chemistry to biology, but not the reverse. I'm happy rolling downhill to where the big questions hide."

Barbara Imperiali 4

References